面向国际患者的CAR-T、干细胞、医疗旅游和医疗政策最新动态。AI精选并标注来源。
Cell therapy has achieved a new breakthrough: iPSC (induced pluripotent stem cell) technology has entered the clinical application stage in Shanghai. This technology promises new treatment pathways for difficult diseases such as Parkinson's disease, macular degeneration and diabetes, attracting wide
Read articleCerebral palsy is a common motor dysfunction disease in children. Research on umbilical cord blood stem cell treatment for pediatric cerebral palsy has made positive progress, bringing new hope to affected families.
Read articleKnee osteoarthritis is a common disease troubling middle-aged and elderly people. Mesenchymal stem cell joint injection, as a regenerative medicine therapy, is providing a new option for patients with early to mid-stage knee osteoarthritis to relieve pain and delay surgery.
Read articleiPSC (induced pluripotent stem cell) derived cell therapy for macular degeneration has entered the clinical stage, bringing new treatment possibilities for patients with retinal diseases such as age-related macular degeneration. The therapy uses the patient's own cells reprogrammed to reduce immune
Read articleChina has made significant progress in stem cell therapy for diabetes: several patients with type 1 diabetes who received stem cell treatment have successfully discontinued insulin injections, and some have remained medication-free for several years. This achievement brings new hope to diabetes pati
Read articleJiahui International Hospital announced the adoption of a next-generation iPSC preparation and treatment platform, covering Parkinson's disease, diabetes, cardiovascular diseases, and more.
Read articleGet the latest medical insights and healthcare news delivered to your inbox.